Opko Health, Inc.
OPK
$1.38
-$0.005-0.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.93% | -13.66% | 0.95% | -2.78% | -31.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.93% | -13.66% | 0.95% | -2.78% | -31.36% |
| Cost of Revenue | -10.91% | -10.02% | -17.36% | 7.93% | -1.58% |
| Gross Profit | -30.87% | -41.49% | 114.25% | -59.78% | -74.55% |
| SG&A Expenses | -13.40% | -15.79% | -8.03% | 35.94% | -13.75% |
| Depreciation & Amortization | -4.78% | -7.35% | -5.33% | -5.11% | -5.18% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.10% | -11.44% | -13.62% | 15.07% | -5.64% |
| Operating Income | 2.74% | 6.02% | 52.01% | -63.70% | -982.13% |
| Income Before Tax | -1,435.38% | 11.78% | 148.24% | 161.76% | 35.82% |
| Income Tax Expenses | -4,928.21% | -327.41% | 448.00% | 287.28% | -108.89% |
| Earnings from Continuing Operations | -1,340.48% | 17.38% | 121.10% | 129.47% | 47.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,340.48% | 17.38% | 121.10% | 129.47% | 47.53% |
| EBIT | 2.74% | 6.02% | 52.01% | -63.70% | -982.13% |
| EBITDA | 1.50% | 4.32% | 78.88% | -111.97% | -211.86% |
| EPS Basic | -1,172.97% | 13.04% | 123.39% | 131.85% | 43.30% |
| Normalized Basic EPS | -1,256.84% | 9.51% | 273.44% | -80.91% | -439.29% |
| EPS Diluted | -1,172.97% | 13.04% | 119.28% | 128.29% | 43.30% |
| Normalized Diluted EPS | -1,256.84% | 9.51% | 223.31% | -25.84% | -439.29% |
| Average Basic Shares Outstanding | 13.02% | -4.99% | -9.94% | -7.57% | -7.25% |
| Average Diluted Shares Outstanding | 13.02% | -4.99% | 26.66% | 32.85% | -7.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |